Efficacy and long-term safety of oral semaglutide versus sitagliptin in subjects with type 2 diabetes

Update Il y a 4 ans
Reference: U1111-1168-4339

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

To compare the effect of once-daily dosing of three dose levels (3 mg, 7 mg and 14 mg) of oral semaglutide versus sitagliptin 100 mg once-daily, both in combination with metformin with or without sulfonylurea (SU), on glycaemic control in subjects with type 2 diabetes mellitus (T2DM)


Inclusion criteria

  • Diabetes Mellitus, Type 2

Links